Head-to-head
Hims & Hers vs Gala GLP-1
Compared on both medications across the eight dimensions this database records. They differ on 7 of those eight. Gala GLP-1 is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Hims & Hers is $697 a month all-in for tirzepatide; Gala GLP-1 is $179. Over twelve months that is $8,364 against $2,148. Value Scores are 27.5 and 91.6 out of 100.
Tirzepatide
Plan pages: Hims & Hers plans · Gala GLP-1 plans
At 10 mg/week, Hims & Hers is $697 a month all-in and Gala GLP-1 is $179 — $518 apart, or $6,216 across a year. Over twelve months the totals are $8,364 (billed monthly) and $2,148 (billed monthly).
Hims & Hers charges a flat $548 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
Gala GLP-1 charges a flat $179 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
| Dose | Hims & Hers | Rank | Gala GLP-1 | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $548 | 30/31 | $179 | 4/31 | Gala GLP-1 by $369 |
| 5 mg | — | — | $179 | 2/17 | only Gala GLP-1 publishes |
| 7.5 mg | — | — | $179 | 2/17 | only Gala GLP-1 publishes |
| 10 mg | $548 | 25/27 | $179 | 2/27 | Gala GLP-1 by $369 |
| 12.5 mg | — | — | $179 | 2/17 | only Gala GLP-1 publishes |
| 15 mg | — | — | $179 | 2/17 | only Gala GLP-1 publishes |
Gala GLP-1 is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, Hims & Hers sits 25 of 27 on all-in monthly cost and Gala GLP-1 sits 3. There are 21 other programs priced between them. The field median is $339 and the floor is $169, so Gala GLP-1 is below the median and the other is above it. Hims & Hers is $528 above the cheapest tirzepatide program on record. Gala GLP-1 is $10 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Hims & Hers undercuts it by $-248, Gala GLP-1 by $270. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Hims & Hers | Gala GLP-1 | Cheaper |
|---|---|---|---|
| Month to month | $548 | $179 | Gala GLP-1 by $369 |
| 3-month term | — | $199 | only Gala GLP-1 publishes this term |
| Settled dose | Hims & Hers | Gala GLP-1 | Difference |
|---|---|---|---|
| 2.5 mg | $8,364 | $2,148 | $6,216 apart |
| 5 mg | — | $2,148 | one side unpriced |
| 7.5 mg | — | $2,148 | one side unpriced |
| 10 mg | $8,364 | $2,148 | $6,216 apart |
| 12.5 mg | — | $2,148 | one side unpriced |
| 15 mg | — | $2,148 | one side unpriced |
Hims & Hers publishes no rate for 3-month term, 6-month term, 12-month term; Gala GLP-1 publishes none for 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $8,364 on Hims & Hers and $2,148 on Gala GLP-1. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Hims & Hers publishes no price at 2 of the 6 doses, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 27.5 for Hims & Hers and 91.6 for Gala GLP-1, against a tirzepatide category floor of $169. Gala GLP-1 leads by 64.1 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Hims & Hers | 17.0 | 10.5 | 0 | 0 | 27.5 |
| Gala GLP-1 | 66.1 | 10.5 | 10 | 5 | 91.6 |
Semaglutide
Plan pages: Hims & Hers plans · Gala GLP-1 plans
At 2.4 mg/week, Hims & Hers is $602 a month all-in and Gala GLP-1 is $179 — $423 apart, or $5,076 across a year. Over twelve months the totals are $7,224 (billed monthly) and $2,148 (billed monthly).
Hims & Hers charges a flat $453 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
Gala GLP-1 charges a flat $179 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Gala GLP-1 is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 25.5 for Hims & Hers and 75.9 for Gala GLP-1, against a semaglutide category floor of $129. Gala GLP-1 leads by 50.4 points, driven mostly by price.
Where the two programs differ
All-in monthly
Gala GLP-1 is cheaper month to month — $179 against $697, a gap of $518 every month, or $6,216 across a year if both rates hold.
Cancellation terms
Cancellation differs: Hims & Hers states Cancel anytime, while Gala GLP-1 states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Hims & Hers asks for Membership month-to-month ($39 first month); Gala GLP-1 asks for 3-month plan or standard monthly; confirm exact terms at enrollment. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Gala GLP-1 charges one price at every dose; Hims & Hers prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Membership fee
Hims & Hers charges a membership of $149 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.
Shipping
Hims & Hers bills shipping separately at $5; the other includes it.
Twelve-month cost
Over twelve months the totals are $8,364 for Hims & Hers and $2,148 for Gala GLP-1. Gala GLP-1 is lower by $6,216 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Evidence status
Both figures carry the same evidence status, reported: sourced from dated third-party reporting; first-party capture pending. Neither is stronger than the other on provenance.
What each record says
Hims & Hers Official site
After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping.
It names its compounding pharmacy — Brand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy, recorded as Brand channel — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Membership month-to-month ($39 first month); cancellation is Cancel anytime; availability is stated as 50 states.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — Post-settlement pricing reported May–Jun 2026 (Wegovy $299 / oral $249 / Zepbound $399 + $149 membership + $5 shipping); first-party checkout capture pending
Watch: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
Gala GLP-1 Official site
Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacies (not named publicly), so who actually makes the medication cannot be independently verified; commitment terms are 3-month plan or standard monthly; confirm exact terms at enrollment; cancellation is Per provider terms; availability is stated as All 50 states (per provider claim; confirm at intake).
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture 2026-07-14
Watch: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.
What neither record tells you
Hims & Hers does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
Gala GLP-1 does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says All 50 states (per provider claim; confirm at intake)
- no specific cancellation or refund terms
Ask Hims & Hers and Gala GLP-1 for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. Hims & Hers, Gala GLP-1 carry a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Gala GLP-1 Official site wins this matchup. If you expect to titrate to the top of the ladder, gala glp-1's flat pricing is worth more than the headline gap suggests; if you want to be able to pause without still paying, gala glp-1 carries no membership.
Both figures should be checked at the provider's own checkout before you pay. Hims & Hers's tirzepatide price is reported as of 2026-08-11; Gala GLP-1's is reported as of 2026-07-14.
Questions
Is Hims & Hers or Gala GLP-1 cheaper for tirzepatide?
Gala GLP-1 is cheaper on all-in monthly cost at 10 mg/week: $179 against $697, a difference of $518 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Hims & Hers versus Gala GLP-1?
Hims & Hers works out to $8,364 across twelve months and Gala GLP-1 to $2,148, on the plan terms each publishes.
Does Hims & Hers or Gala GLP-1 raise the price as the dose goes up?
Hims & Hers: yes, it prices by dose. Gala GLP-1: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Hims & Hers and Gala GLP-1 differ?
7 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Hims & Hers and Gala GLP-1 names its pharmacy?
Hims & Hers does — Brand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy. Gala GLP-1 does not, recording only Partner 503A pharmacies (not named publicly), so who makes its medication cannot be independently verified.
How well evidenced are the Hims & Hers and Gala GLP-1 prices?
Hims & Hers's tirzepatide figure is reported — sourced from dated third-party reporting; first-party capture pending — captured 2026-08-11. Gala GLP-1's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Gala GLP-1, at $179 a month all-in against $602 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: Hims & Hers official site · Gala GLP-1 official site. Compounded tirzepatide and semaglutide are not FDA-approved products.